Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Piet Ost

Showing results (111-120 of 334) with videos related to

Pageof 34
Sort By:
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Outcome for Patients With Pathologic Node-Positive Prostate Cancer Treated With Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy: A Case-Matched Analysis of pN1 and pN0 PatientsAnnelies Van Hemelryk, Gert De Meerleer, Piet Ost, et al.
BJU International|December 2, 2017
Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancerRenée Bultijnck, Inge Van de Caveye, Elke Rammant, et al.
European Urology|July 21, 2021
The European Urology Commitment to Gender Equity and Diversity: Expanding Cognitive Diversity through Inclusivity at the PodiumSarah P Psutka, Todd Morgan, Maarten Albersen, et al.
European Urology Focus|March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Journal of Medical Imaging and Radiation Oncology|August 17, 2016
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (<sup>18</sup> F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trialDieter Berwouts, Katrien De Wolf, Wilfried De Neve, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: treatment results for 47 patientsFilip Claus, Tom Boterberg, Piet Ost, et al.
European Urology Oncology|August 15, 2019
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working GroupJoe M O'Sullivan, Joan Carles, Richard Cathomas, et al.
Practical Radiation Oncology|May 24, 2025
Combining Radiation Therapy With Immune Checkpoint Inhibitors for the Management of Muscle-Invasive Bladder Cancer: A Comprehensive Systematic Review From the Y-ECI ROSC EORTC GroupVérane Achard, Hoda Abdel-Aty, Victor Duque-Santana, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 23, 2011
Population screening for prostate cancer: an overview of available studies and meta-analysisNicolaas Lumen, Valérie Fonteyne, Gert De Meerleert, et al.
Journal of Translational Medicine|July 28, 2025
Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapyJoanne B Weidhaas, Kristen M McGreevy, Nicholas Marco, et al.
Pageof 34

Showing results (111-120 of 334) with videos related to

Sort By:
Pageof 34
International Journal of Radiation Oncology, Biology, Physics|September 7, 2016
The Outcome for Patients With Pathologic Node-Positive Prostate Cancer Treated With Intensity Modulated Radiation Therapy and Androgen Deprivation Therapy: A Case-Matched Analysis of pN1 and pN0 PatientsAnnelies Van Hemelryk, Gert De Meerleer, Piet Ost, et al.
BJU International|December 2, 2017
Clinical pathway improves implementation of evidence-based strategies for the management of androgen deprivation therapy-induced side effects in men with prostate cancerRenée Bultijnck, Inge Van de Caveye, Elke Rammant, et al.
European Urology|July 21, 2021
The European Urology Commitment to Gender Equity and Diversity: Expanding Cognitive Diversity through Inclusivity at the PodiumSarah P Psutka, Todd Morgan, Maarten Albersen, et al.
European Urology Focus|March 23, 2022
Clinical Trial Protocol for ProBio: An Outcome-adaptive and Randomised Multiarm Biomarker-driven Study in Patients with Metastatic Prostate CancerBram De Laere, Alessio Crippa, Andrea Discacciati, et al.
Journal of Medical Imaging and Radiation Oncology|August 17, 2016
Variations in target volume definition and dose to normal tissue using anatomic versus biological imaging (<sup>18</sup> F-FDG-PET) in the treatment of bone metastases: results from a 3-arm randomized phase II trialDieter Berwouts, Katrien De Wolf, Wilfried De Neve, et al.
International Journal of Radiation Oncology, Biology, Physics|November 7, 2002
Postoperative radiotherapy for adenocarcinoma of the ethmoid sinuses: treatment results for 47 patientsFilip Claus, Tom Boterberg, Piet Ost, et al.
European Urology Oncology|August 15, 2019
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working GroupJoe M O'Sullivan, Joan Carles, Richard Cathomas, et al.
Practical Radiation Oncology|May 24, 2025
Combining Radiation Therapy With Immune Checkpoint Inhibitors for the Management of Muscle-Invasive Bladder Cancer: A Comprehensive Systematic Review From the Y-ECI ROSC EORTC GroupVérane Achard, Hoda Abdel-Aty, Victor Duque-Santana, et al.
International Journal of Urology : Official Journal of the Japanese Urological Association|November 23, 2011
Population screening for prostate cancer: an overview of available studies and meta-analysisNicolaas Lumen, Valérie Fonteyne, Gert De Meerleert, et al.
Journal of Translational Medicine|July 28, 2025
Germline microRNA-based signatures predict toxicity and response to anti-CTLA-4 therapyJoanne B Weidhaas, Kristen M McGreevy, Nicholas Marco, et al.
Pageof 34